Your browser doesn't support javascript.
loading
Development and extensive analytical validation of deep amplicon sequencing for detecting KRAS and NRAS mutations in metastatic colorectal cancer samples.
Slavkovský, Rastislav; Stránská, Jana; Vensková, Veronika; Jancik, Sylwia; Kotková, Lucie; Simová, Jarmila; Vojta, Petr; Flodr, Patrik; Bartousková, Marie; Studentová, Hana; Hajdúch, Marián; Drábek, Jirí.
Afiliação
  • Slavkovský R; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Stránská J; Laboratory of Experimental Medicine, University Hospital, Olomouc, Czech Republic.
  • Vensková V; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Jancik S; Department of Neurology, University Hospital, Olomouc, Czech Republic.
  • Kotková L; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Simová J; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Vojta P; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Flodr P; Department of Neurology, University Hospital, Olomouc, Czech Republic.
  • Bartousková M; CGB Laboratory, Inc., Ostrava, Czech Republic.
  • Studentová H; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Hajdúch M; Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Drábek J; Department of Oncology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
Neoplasma ; 69(1): 203-215, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34881628

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas Proto-Oncogênicas p21(ras) Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas Proto-Oncogênicas p21(ras) Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article